ERBB2 and triple-negative breast carcinoma: Metaplastic adenosquamous human breast tumours, as a subset of triple-negative breast cancer, would be expected to fall within the HER2-non-amplified tumour definition, although their overall rarity means they would only make up a very small proportion of that group.